Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-01-25
2005-01-25
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S210190, C514S233500, C514S256000, C514S307000, C514S320000, C514S337000, C514S422000, C544S062000, C544S151000, C544S153000, C544S333000, C548S525000, C548S950000, C546S139000, C546S144000, C546S148000, C546S196000, C546S282700, C546S284100
Reexamination Certificate
active
06846817
ABSTRACT:
The invention provides nicotine receptor agonists of formula I:wherein R1, x, y, and n have any of the values given in the specification, or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions comprising such a compound or salt, methods for preparing such a compound or salt, and methods for modulating (e.g. antagonizing or activating) nicotine receptors with such a compound or salt.
REFERENCES:
patent: 3927023 (1975-12-01), Brown et al.
patent: 4173640 (1979-11-01), Hauck et al.
patent: 4210655 (1980-07-01), Schenker et al.
patent: 4339384 (1982-07-01), Maillard et al.
patent: 4411908 (1983-10-01), Chapleo et al.
patent: 4775675 (1988-10-01), Gyorgydeak et al.
patent: 4940710 (1990-07-01), Sum et al.
patent: 5847159 (1998-12-01), Kai et al.
patent: 613452 (1979-09-01), None
patent: 2408476 (1974-09-01), None
patent: 2408476 (1975-12-01), None
patent: 115142 (1984-08-01), None
patent: 59204190 (1984-11-01), None
patent: 10-175862 (1998-06-01), None
patent: WO 9723216 (1997-07-01), None
patent: 9723216 (1997-07-01), None
patent: 9745424 (1997-12-01), None
patent: WO 0076990 (2000-12-01), None
Schmitt, J.D. et al, “Annual Reports Med. Chem.”, 35, 2000, 41-51.*
Shridhar, D. R.; Sastry, C. V. Reddy; Lal, Kulbhushan; Rao, C. Seshagiri; Taneja, V., Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 18B(3), 254-6 (English) 1979.*
Johansson, Gary; Brisander, Magnus; Sundquist, Staffan; Hacksell, Uli, Chirality, 10(9), 813-820 (English) 1998.*
Document No. 102:185092 Benzofuranylmorpholines. (Kaken Pharmaceutical Co., Ltd., Japan). Jpn. Kokai Tokkyo Koho JP 59204190 A2, Chemical Abstracts.*
Chapleo, C.B., et al., “a-Adrenoreceptor reagents. 2. Effects of modification of the 1,4-benzodioxan ring system on a-adrenoreceptor activity”,Journal of Medicinal Chemistry, 27(5), pp. 570-576, (1984).
Dolby, L.J., et al., “New reactions of 3-vinylindoles”,Tet, vol. 24, No. 21, 6377-6386, (1968).
Berch Mark L.
Regents of the University of Minnesota
Schwegman Lundberg Woessner & Kluth P.A.
LandOfFree
Nicotine receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nicotine receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nicotine receptor ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3392865